| 1 |
33408782 | EZH2 activates CHK1 signaling to promote ovarian cancer chemoresistance by maintaining the properties of cancer stem cells. | 2021 |
1 |
| 2 |
33261142 | Checkpoint Kinase 1 Pharmacological Inhibition Synergizes with DNA-Damaging Agents and Overcomes Platinum Resistance in Basal-Like Breast Cancer. | 2020 Nov 27 |
1 |
| 3 |
28888100 | Chk1 Inhibitor SCH900776 Effectively Potentiates the Cytotoxic Effects of Platinum-Based Chemotherapeutic Drugs in Human Colon Cancer Cells. | 2017 Oct |
3 |
| 4 |
27196780 | Dual mTORC1/2 Inhibition as a Novel Strategy for the Resensitization and Treatment of Platinum-Resistant Ovarian Cancer. | 2016 Jul |
2 |
| 5 |
27905519 | The impact of DNA damage response gene polymorphisms on therapeutic outcomes in late stage ovarian cancer. | 2016 Dec 1 |
1 |
| 6 |
22905093 | Molecular resistance fingerprint of pemetrexed and platinum in a long-term survivor of mesothelioma. | 2012 |
1 |